During the past decade, Centralia Oncology Clinic conducted 170 clinical trials. In the 10-year time frame, 170 clinical trials started and 85 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 56 clinical trials started and 62 clinical trials were completed. i.e. 110.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centralia Oncology Clinic" #1 sponsor was "National Cancer Institute (NCI)" with 110 trials, followed by "SWOG Cancer Research Network" with 50 trials sponsored, "Alliance for Clinical Trials in Oncology" with 39 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 22 trials sponsored and "NRG Oncology" with 22 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centralia Oncology Clinic" #1 collaborator was "National Cancer Institute (NCI)" with 136 trials as a collaborator, "NRG Oncology" with 23 trials as a collaborator, "Canadian Cancer Trials Group" with 11 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 3 trials as a collaborator and "AstraZeneca" with 2 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Centralia Oncology Clinic" are "Stage IV Lung Cancer AJCC v8" (11 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Invasive Breast Carcinoma" (9 trials), "Recurrent Lung Non-Small Cell Carcinoma" (9 trials) and "Recurrent Ovarian Carcinoma" (8 trials). Many other conditions were trialed in "Centralia Oncology Clinic" in a lesser frequency.

Most popular intervention types in "Centralia Oncology Clinic" are "Drug" (190 trials), "Other" (155 trials), "Biological" (98 trials), "Procedure" (68 trials) and "Radiation" (35 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (65 trials), "Quality-of-Life Assessment" (60 trials), "Questionnaire Administration" (48 trials), "Biospecimen Collection" (38 trials) and "Computed Tomography" (37 trials). Other intervention names were less common.

The vast majority of trials in "Centralia Oncology Clinic" are 209 trials for "All" genders, 36 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Centralia Oncology Clinic". undefined are not yet recruiting, 80 are recruiting, 108 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 42 completed trials in Centralia Oncology Clinic, 9 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Centralia Oncology Clinic, 10 "Phase 1" clinical trials were conducted, 129 "Phase 2" clinical trials and 119 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".